Orexin A

What Orexin A is, structurally

Orexin A is a peptide of thirty-three residues. The product page describes it as folded, carrying two internal disulfide bridges and a modified N-terminus, and the deposited formula for this CAS agrees on the first of those: four sulfurs, which is exactly the count two disulfide bridges require.

Those four sulfurs are the whole handling story. Because all four are committed to cross-links, there is no methionine here and therefore no sulfoxide route, which removes the oxidation liability that dominates many peptides of this size. What replaces it is more troublesome.

Reducing agents must be kept away from this material entirely, and the product page says so in its own handling notes. Dithiothreitol, TCEP and 2-mercaptoethanol open both bridges, and an unfolded molecule is a different substance from the folded one in the vial.

The second risk is scrambling, and the arithmetic makes it concrete. Four cysteines can be paired in three distinct ways, of which only one is correct. The other two arrangements have the same formula and the same mass as the right one, so a scrambled molecule is isomeric with correct material and passes a mass check unchanged. Disulfide exchange is catalysed by thiolate, which forms as pH rises, so alkaline buffers are what allow the rearrangement to happen.

The modified N-terminus has a separate and quite practical consequence. A blocked alpha-amino group cannot be attacked by the Edman reagent, so Edman degradation cannot sequence this peptide at all, and any sequence confirmation must come from mass spectrometry.

Reconstitution and handling

Sterile water is the default solvent, and PBS or an appropriate assay buffer is equally suitable. Keep the pH at or below neutral, since mildly acidic to neutral conditions suppress the thiolate-mediated exchange described above while alkaline conditions promote it.

Add diluent slowly down the inside wall of the vial, swirl gently, and let the solution clarify. Do not vortex; on a folded molecule the mechanical stress is worth avoiding on its own account.

Do not add a reducing agent, for the reason above.

Adsorptive loss deserves allowance at low concentration, with low-protein-binding tubes reducing measured loss. At three and a half kilodaltons the effect is modest but real.

This is laboratory preparation chemistry, not dosing, administration, or protocol guidance of any kind.

Storage and stability

Store the lyophilized powder at -20 degrees C, sealed, desiccated and protected from light, and let a cold vial warm before opening. Reconstituted, hold at 2 to 8 degrees C, or aliquot and freeze rather than thawing repeatedly. Freeze-thaw is a greater liability for a folded molecule than for a linear one, since the damage is structural as well as chemical.

With no methionine and no free thiol, air exposure matters less here than for most peptides carrying sulfur. The dominant route is not oxidation but rearrangement: the two bridges reshuffling into one of the two wrong pairings, which cold and near-neutral pH both suppress.

The formula's high oxygen count indicates residues capable of the ordinary hydrolytic liabilities, aspartyl isomerisation and asparaginyl or glutaminyl deamidation, but without a sequence on file this page will not name positions for them.

These are storage conditions for the material, not dosing or administration guidance.

How Orexin A is tested

Reversed-phase HPLC establishes chromatographic purity as area percent. The most informative check on a molecule of this kind is comparative rather than absolute: running the material alongside a deliberately reduced aliquot separates correctly folded material from reduced or scrambled forms, which differ in retention even where they do not differ in mass.

Area percent is a chromatographic measure and not peptide content by weight. Solid-phase synthesis delivers a salt, and residual trifluoroacetate is its own impurity class.

Mass spectrometry confirms identity, and two results are worth anticipating. A figure four units above the expected mass indicates fully reduced material, since each of the two disulfides formed removes two hydrogens. Scrambled material, by contrast, returns the expected mass exactly, which is why the chromatographic comparison above is the check that actually earns its place.

These describe general methodology, not a claim about any particular batch.

Handling FAQ

Can a reducing agent be added to help this dissolve? No. The molecule holds two disulfide bridges, and dithiothreitol, TCEP or 2-mercaptoethanol will open both. Reduced material is a different substance from what the vial contains, and removing the reagent afterwards does not restore the original pairings.

Will a mass check confirm the folding is correct? No, and this is the important limitation. Four cysteines can pair three different ways, and all three have identical formulas and masses. A mass spectrum confirms the chain but says nothing about which pairing it holds; only a chromatographic comparison against reduced material will show that.

Full specifications for Orexin A.